aluates Reports

$ 0.0

Automative

Trastuzumab Monoclonal Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: November 2024

Report Code: QYRE-Auto-28U14352

Global Trastuzumab Monoclonal Antibody Market Research Report 2023

BUY CHAPTERS

Trastuzumab Monoclonal Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-28U14352

Report

November 2024

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Trastuzumab Monoclonal Antibody - Market Size

The global market for Trastuzumab Monoclonal Antibody was estimated to be worth US$ 4512 million in 2023 and is forecast to a readjusted size of US$ 6303.7 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

Trastuzumab Monoclonal Antibody - Market

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.

North American market for Trastuzumab Monoclonal Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Trastuzumab Monoclonal Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Trastuzumab Monoclonal Antibody was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Trastuzumab Monoclonal Antibody include Roche, Amgen, Pfizer, Organon, Teva and Viatris, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Trastuzumab Monoclonal Antibody, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Trastuzumab Monoclonal Antibody by region & country, by Type, and by Application.

The Trastuzumab Monoclonal Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trastuzumab Monoclonal Antibody.

Market Segmentation

Scope of Trastuzumab Monoclonal Antibody - Market Report

Report Metric	Details
Report Name	Trastuzumab Monoclonal Antibody - Market
Forecasted market size in 2030	US$ 6303.7 million
CAGR	4.8%
Forecasted years	2024 - 2030
Segment by Type:	Brand Biosimilar
Segment by Application	Breast Cancer Stomach Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, Pfizer, Organon, Teva, Viatris
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Trastuzumab Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Trastuzumab Monoclonal Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Trastuzumab Monoclonal Antibody in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Trastuzumab Monoclonal Antibody - Market size in 2030?

Ans: The Trastuzumab Monoclonal Antibody - Market size in 2030 will be US$ 6303.7 million.

Who are the main players in the Trastuzumab Monoclonal Antibody - Market report?

Ans: The main players in the Trastuzumab Monoclonal Antibody - Market are Roche, Amgen, Pfizer, Organon, Teva, Viatris

What are the Application segmentation covered in the Trastuzumab Monoclonal Antibody - Market report?

Ans: The Applications covered in the Trastuzumab Monoclonal Antibody - Market report are Breast Cancer, Stomach Cancer

What are the Type segmentation covered in the Trastuzumab Monoclonal Antibody - Market report?

Ans: The Types covered in the Trastuzumab Monoclonal Antibody - Market report are Brand, Biosimilar

1 Market Overview

1.1 Trastuzumab Monoclonal Antibody Product Introduction

1.2 Global Trastuzumab Monoclonal Antibody Market Size Forecast

1.2.1 Global Trastuzumab Monoclonal Antibody Sales Value (2019-2030)

1.2.2 Global Trastuzumab Monoclonal Antibody Sales Volume (2019-2030)

1.2.3 Global Trastuzumab Monoclonal Antibody Sales Price (2019-2030)

1.3 Trastuzumab Monoclonal Antibody Market Trends & Drivers

1.3.1 Trastuzumab Monoclonal Antibody Industry Trends

1.3.2 Trastuzumab Monoclonal Antibody Market Drivers & Opportunity

1.3.3 Trastuzumab Monoclonal Antibody Market Challenges

1.3.4 Trastuzumab Monoclonal Antibody Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Trastuzumab Monoclonal Antibody Players Revenue Ranking (2023)

2.2 Global Trastuzumab Monoclonal Antibody Revenue by Company (2019-2024)

2.3 Global Trastuzumab Monoclonal Antibody Players Sales Volume Ranking (2023)

2.4 Global Trastuzumab Monoclonal Antibody Sales Volume by Company Players (2019-2024)

2.5 Global Trastuzumab Monoclonal Antibody Average Price by Company (2019-2024)

2.6 Key Manufacturers Trastuzumab Monoclonal Antibody Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Trastuzumab Monoclonal Antibody Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Trastuzumab Monoclonal Antibody

2.9 Trastuzumab Monoclonal Antibody Market Competitive Analysis

2.9.1 Trastuzumab Monoclonal Antibody Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Trastuzumab Monoclonal Antibody Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trastuzumab Monoclonal Antibody as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Brand

3.1.2 Biosimilar

3.2 Global Trastuzumab Monoclonal Antibody Sales Value by Type

3.2.1 Global Trastuzumab Monoclonal Antibody Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Trastuzumab Monoclonal Antibody Sales Value, by Type (2019-2030)

3.2.3 Global Trastuzumab Monoclonal Antibody Sales Value, by Type (%) (2019-2030)

3.3 Global Trastuzumab Monoclonal Antibody Sales Volume by Type

3.3.1 Global Trastuzumab Monoclonal Antibody Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Trastuzumab Monoclonal Antibody Sales Volume, by Type (2019-2030)

3.3.3 Global Trastuzumab Monoclonal Antibody Sales Volume, by Type (%) (2019-2030)

3.4 Global Trastuzumab Monoclonal Antibody Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Breast Cancer

4.1.2 Stomach Cancer

4.2 Global Trastuzumab Monoclonal Antibody Sales Value by Application

4.2.1 Global Trastuzumab Monoclonal Antibody Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Trastuzumab Monoclonal Antibody Sales Value, by Application (2019-2030)

4.2.3 Global Trastuzumab Monoclonal Antibody Sales Value, by Application (%) (2019-2030)

4.3 Global Trastuzumab Monoclonal Antibody Sales Volume by Application

4.3.1 Global Trastuzumab Monoclonal Antibody Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Trastuzumab Monoclonal Antibody Sales Volume, by Application (2019-2030)

4.3.3 Global Trastuzumab Monoclonal Antibody Sales Volume, by Application (%) (2019-2030)

4.4 Global Trastuzumab Monoclonal Antibody Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Trastuzumab Monoclonal Antibody Sales Value by Region

5.1.1 Global Trastuzumab Monoclonal Antibody Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Trastuzumab Monoclonal Antibody Sales Value by Region (2019-2024)

5.1.3 Global Trastuzumab Monoclonal Antibody Sales Value by Region (2025-2030)

5.1.4 Global Trastuzumab Monoclonal Antibody Sales Value by Region (%), (2019-2030)

5.2 Global Trastuzumab Monoclonal Antibody Sales Volume by Region

5.2.1 Global Trastuzumab Monoclonal Antibody Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Trastuzumab Monoclonal Antibody Sales Volume by Region (2019-2024)

5.2.3 Global Trastuzumab Monoclonal Antibody Sales Volume by Region (2025-2030)

5.2.4 Global Trastuzumab Monoclonal Antibody Sales Volume by Region (%), (2019-2030)

5.3 Global Trastuzumab Monoclonal Antibody Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

5.4.2 North America Trastuzumab Monoclonal Antibody Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

5.5.2 Europe Trastuzumab Monoclonal Antibody Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

5.6.2 Asia Pacific Trastuzumab Monoclonal Antibody Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

5.7.2 South America Trastuzumab Monoclonal Antibody Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

5.8.2 Middle East & Africa Trastuzumab Monoclonal Antibody Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Value

6.2.1 Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

6.2.2 Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

6.3.2 United States Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Trastuzumab Monoclonal Antibody Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

6.4.2 Europe Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Trastuzumab Monoclonal Antibody Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

6.5.2 China Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

6.5.3 China Trastuzumab Monoclonal Antibody Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

6.6.2 Japan Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Trastuzumab Monoclonal Antibody Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

6.7.2 South Korea Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Trastuzumab Monoclonal Antibody Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

6.8.2 Southeast Asia Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Trastuzumab Monoclonal Antibody Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Trastuzumab Monoclonal Antibody Sales Value, 2019-2030

6.9.2 India Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

6.9.3 India Trastuzumab Monoclonal Antibody Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Roche

7.1.1 Roche Company Information

7.1.2 Roche Introduction and Business Overview

7.1.3 Roche Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Roche Trastuzumab Monoclonal Antibody Product Offerings

7.1.5 Roche Recent Development

7.2 Amgen

7.2.1 Amgen Company Information

7.2.2 Amgen Introduction and Business Overview

7.2.3 Amgen Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Amgen Trastuzumab Monoclonal Antibody Product Offerings

7.2.5 Amgen Recent Development

7.3 Pfizer

7.3.1 Pfizer Company Information

7.3.2 Pfizer Introduction and Business Overview

7.3.3 Pfizer Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Pfizer Trastuzumab Monoclonal Antibody Product Offerings

7.3.5 Pfizer Recent Development

7.4 Organon

7.4.1 Organon Company Information

7.4.2 Organon Introduction and Business Overview

7.4.3 Organon Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Organon Trastuzumab Monoclonal Antibody Product Offerings

7.4.5 Organon Recent Development

7.5 Teva

7.5.1 Teva Company Information

7.5.2 Teva Introduction and Business Overview

7.5.3 Teva Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Teva Trastuzumab Monoclonal Antibody Product Offerings

7.5.5 Teva Recent Development

7.6 Viatris

7.6.1 Viatris Company Information

7.6.2 Viatris Introduction and Business Overview

7.6.3 Viatris Trastuzumab Monoclonal Antibody Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Viatris Trastuzumab Monoclonal Antibody Product Offerings

7.6.5 Viatris Recent Development

8 Industry Chain Analysis

8.1 Trastuzumab Monoclonal Antibody Industrial Chain

8.2 Trastuzumab Monoclonal Antibody Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Trastuzumab Monoclonal Antibody Sales Model

8.5.2 Sales Channel

8.5.3 Trastuzumab Monoclonal Antibody Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Trastuzumab Monoclonal Antibody Market Trends

Table 2. Trastuzumab Monoclonal Antibody Market Drivers & Opportunity

Table 3. Trastuzumab Monoclonal Antibody Market Challenges

Table 4. Trastuzumab Monoclonal Antibody Market Restraints

Table 5. Global Trastuzumab Monoclonal Antibody Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Trastuzumab Monoclonal Antibody Revenue Market Share by Company (2019-2024)

Table 7. Global Trastuzumab Monoclonal Antibody Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Trastuzumab Monoclonal Antibody Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Trastuzumab Monoclonal Antibody Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Trastuzumab Monoclonal Antibody Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Trastuzumab Monoclonal Antibody Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Trastuzumab Monoclonal Antibody

Table 13. Global Trastuzumab Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trastuzumab Monoclonal Antibody as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Trastuzumab Monoclonal Antibody Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Trastuzumab Monoclonal Antibody Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Trastuzumab Monoclonal Antibody Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Trastuzumab Monoclonal Antibody Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Trastuzumab Monoclonal Antibody Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Trastuzumab Monoclonal Antibody Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Trastuzumab Monoclonal Antibody Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Trastuzumab Monoclonal Antibody Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Trastuzumab Monoclonal Antibody Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Trastuzumab Monoclonal Antibody Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Trastuzumab Monoclonal Antibody Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Trastuzumab Monoclonal Antibody Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Trastuzumab Monoclonal Antibody Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Trastuzumab Monoclonal Antibody Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Trastuzumab Monoclonal Antibody Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Trastuzumab Monoclonal Antibody Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Trastuzumab Monoclonal Antibody Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Trastuzumab Monoclonal Antibody Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Trastuzumab Monoclonal Antibody Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Trastuzumab Monoclonal Antibody Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Trastuzumab Monoclonal Antibody Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Trastuzumab Monoclonal Antibody Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Trastuzumab Monoclonal Antibody Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Trastuzumab Monoclonal Antibody Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Trastuzumab Monoclonal Antibody Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Trastuzumab Monoclonal Antibody Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Trastuzumab Monoclonal Antibody Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Trastuzumab Monoclonal Antibody Sales Value by Region (2019-2024) & (%)

Table 44. Global Trastuzumab Monoclonal Antibody Sales Value by Region (2025-2030) & (%)

Table 45. Global Trastuzumab Monoclonal Antibody Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Trastuzumab Monoclonal Antibody Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Trastuzumab Monoclonal Antibody Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Trastuzumab Monoclonal Antibody Sales Volume by Region (2019-2024) & (%)

Table 49. Global Trastuzumab Monoclonal Antibody Sales Volume by Region (2025-2030) & (%)

Table 50. Global Trastuzumab Monoclonal Antibody Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Trastuzumab Monoclonal Antibody Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Volume, (2025-2030) & (K Units)

Table 57. Roche Company Information

Table 58. Roche Introduction and Business Overview

Table 59. Roche Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Roche Trastuzumab Monoclonal Antibody Product Offerings

Table 61. Roche Recent Development

Table 62. Amgen Company Information

Table 63. Amgen Introduction and Business Overview

Table 64. Amgen Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Amgen Trastuzumab Monoclonal Antibody Product Offerings

Table 66. Amgen Recent Development

Table 67. Pfizer Company Information

Table 68. Pfizer Introduction and Business Overview

Table 69. Pfizer Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Pfizer Trastuzumab Monoclonal Antibody Product Offerings

Table 71. Pfizer Recent Development

Table 72. Organon Company Information

Table 73. Organon Introduction and Business Overview

Table 74. Organon Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Organon Trastuzumab Monoclonal Antibody Product Offerings

Table 76. Organon Recent Development

Table 77. Teva Company Information

Table 78. Teva Introduction and Business Overview

Table 79. Teva Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Teva Trastuzumab Monoclonal Antibody Product Offerings

Table 81. Teva Recent Development

Table 82. Viatris Company Information

Table 83. Viatris Introduction and Business Overview

Table 84. Viatris Trastuzumab Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Viatris Trastuzumab Monoclonal Antibody Product Offerings

Table 86. Viatris Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Trastuzumab Monoclonal Antibody Downstream Customers

Table 90. Trastuzumab Monoclonal Antibody Distributors List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Trastuzumab Monoclonal Antibody Product Picture

Figure 2. Global Trastuzumab Monoclonal Antibody Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Trastuzumab Monoclonal Antibody Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Trastuzumab Monoclonal Antibody Sales Volume (2019-2030) & (K Units)

Figure 5. Global Trastuzumab Monoclonal Antibody Sales Price (2019-2030) & (US$/Unit)

Figure 6. Trastuzumab Monoclonal Antibody Report Years Considered

Figure 7. Global Trastuzumab Monoclonal Antibody Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Trastuzumab Monoclonal Antibody Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Trastuzumab Monoclonal Antibody Revenue in 2023

Figure 10. Trastuzumab Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Brand Picture

Figure 12. Biosimilar Picture

Figure 13. Global Trastuzumab Monoclonal Antibody Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Trastuzumab Monoclonal Antibody Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Trastuzumab Monoclonal Antibody Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Trastuzumab Monoclonal Antibody Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Trastuzumab Monoclonal Antibody Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Breast Cancer

Figure 19. Product Picture of Stomach Cancer

Figure 20. Global Trastuzumab Monoclonal Antibody Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Trastuzumab Monoclonal Antibody Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Trastuzumab Monoclonal Antibody Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Trastuzumab Monoclonal Antibody Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Trastuzumab Monoclonal Antibody Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Trastuzumab Monoclonal Antibody Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Trastuzumab Monoclonal Antibody Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Trastuzumab Monoclonal Antibody Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Trastuzumab Monoclonal Antibody Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Trastuzumab Monoclonal Antibody Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Trastuzumab Monoclonal Antibody Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Trastuzumab Monoclonal Antibody Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Trastuzumab Monoclonal Antibody Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Trastuzumab Monoclonal Antibody Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Trastuzumab Monoclonal Antibody Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Trastuzumab Monoclonal Antibody Sales Volume (%), (2019-2030)

Figure 37. United States Trastuzumab Monoclonal Antibody Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Trastuzumab Monoclonal Antibody Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Trastuzumab Monoclonal Antibody Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Trastuzumab Monoclonal Antibody Sales Value by Application (%), 2023 VS 2030

Figure 43. China Trastuzumab Monoclonal Antibody Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

Figure 45. China Trastuzumab Monoclonal Antibody Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Trastuzumab Monoclonal Antibody Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Trastuzumab Monoclonal Antibody Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Trastuzumab Monoclonal Antibody Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Trastuzumab Monoclonal Antibody Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Trastuzumab Monoclonal Antibody Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Trastuzumab Monoclonal Antibody Sales Value by Application (%), 2023 VS 2030

Figure 55. India Trastuzumab Monoclonal Antibody Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Trastuzumab Monoclonal Antibody Sales Value by Type (%), 2023 VS 2030

Figure 57. India Trastuzumab Monoclonal Antibody Sales Value by Application (%), 2023 VS 2030

Figure 58. Trastuzumab Monoclonal Antibody Industrial Chain

Figure 59. Trastuzumab Monoclonal Antibody Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions